Login

Mike Speetzen, CEO of Polaris, joins 'Closing Bell: Overtime' to discuss investor day, earnings, and the state of the high-ticket consumer market. 00:10:00

Share On Facebook Share On Twitter

Marc Murnaghan - Polaris Renewable Energy Inc.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Bigtincan CEO David Keane discusses strategies for promoting and reselling Bigtincan Hub to customers.
00:10:00
For digital mining solutions, Orica introduces Axis Mining Technology. | Shane Munyard, CEO, Axis Mining Technology Pty Ltd. (TS)
00:10:00
M1 Finance's New $3 Fee: What Are Your Options?
00:10:00
Chargeurs CEO Michael Fribourg Affirms Staying Listed Despite Challenges on BFM Business | Michaël Fribourg - CEO of Chargeurs
00:10:00
Global Geological Cooperation: BGR's Technical Projects and International Partnerships
00:10:00
Prashant Kumar on Reviving YES BANK and Future Growth Strategies | Prashant Kumar, CEO , Yes Bank Ltd.
00:10:00
An Introduction to JPMorgan American Investment Trust | The Association of Investment Companies
00:10:00
Bart Verhaeghe's Vision: The Future of Belgian Football, Real Estate, and Stadium Projects | Bart Verhaeghe, CEO, Club Brugge KV.
00:10:00
Market Resilience and Credit Dynamics: Glenn August on Economic Shifts and Strategic Insights |Glenn August , CEO, Oak Hill Advisors.
00:10:00
Own Real Estate Without the Hassle when real state is hassle|Ellis Hammond,CEO,Symphony Capital LLC
00:10:00
Michael Doss CEO of Graphic Packaging recently invested $600 million in a new facility here in Kalamazoo
00:10:00
we go beyond expectation: helping you achieve a better future|Damon Ficklin,Head of Team, Portfolio Manager,Polen Partners

© 2017 - Neuhu+